Dr Bhaskara Rao Bollineni's Insider Trades & SAST Disclosures
No reported Insider Trades available for Dr Bhaskara Rao Bollineni in the Trendlyne database.
Dr Bhaskara Rao Bollineni's has made SAST transactions in Krishna Institute of Medical Sciences Ltd. recently where a Pledge of 910,000 shares done . Disclosure was reported to the exchange on July 2, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Krishna Institute | Dr. Bhaskara Rao Bollineni | Promoter | Pledge | 24 Dec 2024 | 910,000 | 1,200,000 | - | - | 01 Jul 2022 |
SAST (Reg31) | - | Release | |
| Som Datt Finance | Dr Bhaskara Rao Bollineni & Others | Other | Disposal | 28 Jul 2023 | 3,397,459 | - | 33.95% | - | 21 Jul 2023 21 Jul 2023 |
SAST (29(2)) | - | Off Market | |
| Som Datt Finance | Dr Bhaskara Rao Bollineni | Other | Acquisition | 28 Jul 2023 | 3,542,191 | - | 35.39% | - | 21 Jul 2023 21 Jul 2023 |
SAST (29(2)) | - | Off Market | |
| Som Datt Finance | Dr Bhaskara Rao Bollineni | Other | Acquisition | 28 Jul 2023 | 6,439,650 | 6,441,050 (64.36%) | 64.34% | - | 21 Jul 2023 21 Jul 2023 |
SAST (29(1)) | - | Off Market Transfer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.